Table 1:
Clinical and pathologic information of patients with DNETs who underwent EMR or surgical resection
| Category | Level | Total (%) (n = 104) |
EMR (%) (n = 64) |
SR (%) (n = 40) |
P value |
|---|---|---|---|---|---|
| Sex | Female | 48 (46.2%) | 28 (43.8%) | 20 (50%) | 0.67 |
| Male | 56 (53.8%) | 36 (56.3%) | 20 (50%) | ||
| Age at resection, median (range) | 63.9 (28.5-87) | 69.4 (28.5-87) | 57.9 (36.9-75.6) | <0.001 | |
| BMI at diagnosis, median (range) | 32.9 (18.7-65) | 32.9 (19.7-65) | 33 (18.7-47.9) | 0.79 | |
| Charlson Deyo score | 0 | 31 (31.3%) | 20 (32.3%) | 11 (29.7%) | 0.04 |
| 1 | 37 (37.4%) | 20 (32.3%) | 17 (45.9%) | ||
| 2 | 13 (13.1%) | 6 (9.7%) | 7 (18.9%) | ||
| ≥ 3 | 18 (18.2%) | 16 (25.8%) | 2 (5.4%) | ||
| Grade | 1 | 41 (66.1%) | 27 (73%) | 14 (56%) | 0.21 |
| 2 | 20 (32.3%) | 10 (27%) | 10 (40%) | ||
| 3 | 1 (1.6%) | 0 (0%) | 1 (4%) | ||
| T stage | 1 | 31 (42.5%) | 26 (61.9%) | 5 (16.1%) | <0.001 |
| 2 | 33 (45.2%) | 14 (33.3%) | 19 (61.3%) | ||
| 3 | 6 (8.2%) | 2 (4.8%) | 4 (12.9%) | ||
| 4 | 3 (4.1%) | 0 (0%) | 3 (9.7%) | ||
| N stage | N0 | 70 (74.5%) | 26 (89.7%) | 14 (40%) | <0.001 |
| N1 | 24 (25.5%) | 3 (10.3%) | 21 (60%) | ||
| M stage | M0 | 81 (87.1%) | 54 (98.2%) | 27 (71.1%) | <0.001 |
| M1 | 12 (12.9%) | 1 (1.8%) | 11 (28.9%) | ||
| Tumor size (mm), median (range) | 11 (1-148) | 7 (1-21) | 16 (5-148) | <0.001 |
Bold indicates statistical significance (P < 0.05). Percentages may not sum to 100 due to rounding. Abbreviations: DNET – duodenal neuroendocrine tumor, EMR – endoscopic mucosal resection, SR – surgical resection